#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoidosis Hereditary neuropathic amyloidosis Infertility female Antithrombin III deficiency Atypical haemolytic uraemic syndrome Endometrial adenocarcinoma Arrhythmogenic right ventricular dysplasia Craniocerebral injury Bladder cancer Congenital generalised lipodystrophy Cystic fibrosis lung Non-small cell lung cancer Glioma Congenital pseudarthrosis Iron overload More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Life with Disease Bronchopulmonary dysplasia – Life with Disease Marginal zone lymphoma refractory – Diagnostics Metachromatic leukodystrophy – Basic Information Niemann-Pick disease Haemolytic uraemic syndrome Hereditary hypophosphataemic rickets Tuberous sclerosis complex – Diagnostics Lymphangiosarcoma – Basic Information Krabbe’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SC0062 Vonicog Alfa Poa Pratensis Pollen Extract Hexaminolevulinate INSULIN DETEMIR Atrasentan Hydrochloride Melphalan Hydrochloride Nortriptyline Hydrochloride Lavender Oil Stro-002 GAXILOSE Plerixafor Tofogliflozin Ethambutol Hydrochloride Rebisufligene Etisparvovec Glutenin Lapatinib Esketamine Hydrochloride LUMC-BOB1-B7-TCR.1 Vamorolone More therapies…

    Learn about Your Condition

    Ewing's sarcoma metastatic Enteritis Thrombectomy Cushing's syndrome Tonsillitis Endometrial cancer stage I Premature baby Bone hypertrophy Peripheral artery thrombosis Chronic coronary syndrome Right ventricular dysfunction Hyperinsulinism Hepato-lenticular degeneration Retinoblastoma Autoimmune hepatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theagenio Cancer Hospital of Thessaloniki

Theagenio Cancer Hospital of Thessaloniki

Alexandrou Simeonidi str 2, Thessaloniki, 54639, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Enoxaparin Sodium
    • Warfarin Sodium
    • Acetylsalicylic Acid
    Austria Belgium Czechia Denmark Finland France +10

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Amyloidosis
    Investigated Drugs:
    • GSK5764227
    • Cyclophosphamide Monohydrate
    • Bortezomib
    Greece Italy Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!